|
ZNF675 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.603000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.180230E-01 |
| Normal-vs-Stage2 |
5.259600E-01 |
| Normal-vs-Stage3 |
4.359200E-01 |
| Normal-vs-Stage4 |
3.569200E-01 |
| Stage1-vs-Stage2 |
7.048000E-02 |
| Stage1-vs-Stage3 |
2.581700E-02 |
| Stage1-vs-Stage4 |
2.351900E-02 |
| Stage2-vs-Stage3 |
9.896200E-01 |
| Stage2-vs-Stage4 |
8.723800E-01 |
| Stage3-vs-Stage4 |
8.647200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.602400E-01 |
| Normal-vs-AfricanAmerican |
4.516200E-01 |
| Normal-vs-Asian |
3.979400E-01 |
| Caucasian-vs-AfricanAmerican |
4.364800E-01 |
| Caucasian-vs-Asian |
3.625400E-01 |
| AfricanAmerican-vs-Asian |
7.999400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.094400E-01 |
| Normal-vs-Female |
7.059000E-01 |
| Male-vs-Female |
5.555400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.646170E-01 |
| Normal-vs-Age(41-60Yrs) |
8.662800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.880600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.084400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.117960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.888030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.529800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.928000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.248200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.720800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.640700E-03 |
| Classical-VS-Follicular |
2.480000E-01 |
| Classical-VS-Other |
6.592000E-01 |
| Classical-VS-Normal |
5.277800E-01 |
| Tall-VS-Follicular |
8.299900E-03 |
| Tall-VS-Other |
2.504400E-01 |
| Tall-VS-Normal |
7.600100E-02 |
| Follicular-VS-Other |
9.359800E-01 |
| Follicular-VS-Normal |
1.543380E-01 |
| Other-VS-Normal |
5.740600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.752200E-01 |
| Normal-vs-N1 |
5.778000E-01 |
| N0-vs-N1 |
1.315170E-01 |
|
|
